Novel Psychoactive Substances: The Razor's Edge between Therapeutical Potential and Psychoactive Recreational Misuse
- PMID: 35323718
- PMCID: PMC8950629
- DOI: 10.3390/medicines9030019
Novel Psychoactive Substances: The Razor's Edge between Therapeutical Potential and Psychoactive Recreational Misuse
Abstract
Background: Novel psychoactive substances (NPS) are compounds of natural and synthetic origin, similar to traditional drugs of abuse. NPS are involved in a contemporary trend whose origin lies in a thinner balance between legitimate therapeutic drug research and legislative control. The contemporary NPS trend resulted from the replacement of MDMA by synthetic cathinones in 'ecstasy' during the 2000s. The most common NPS are synthetic cannabinoids and synthetic cathinones. Interestingly, during the last 50 years, these two classes of NPS have been the object of scientific research for a set of health conditions.
Methods: Searches were conducted in the online database PubMed using boolean equations.
Results: Synthetic cannabinoids displayed protective and therapeutic effects for inflammatory, neurodegenerative and oncologic pathologies, activating the immune system and reducing inflammation. Synthetic cathinones act similarly to amphetamine-type stimulants and can be used for depression and chronic fatigue.
Conclusions: Despite the scientific advances in this field of research, pharmacological application of NPS is being jeopardized by fatalities associated with their recreational use. This review addresses the scientific achievements of these two classes of NPS and the toxicological data, ending with a reflection on Illicit and NPS control frames.
Keywords: NPS; synthetic cannabinoids; synthetic cathinones; therapeutic; toxicology.
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
Neuropharmacology of New Psychoactive Substances (NPS): Focus on the Rewarding and Reinforcing Properties of Cannabimimetics and Amphetamine-Like Stimulants.Front Neurosci. 2016 Apr 19;10:153. doi: 10.3389/fnins.2016.00153. eCollection 2016. Front Neurosci. 2016. PMID: 27147945 Free PMC article. Review.
-
An overview of New Psychoactive Substances (NPS) in northeast Brazil: NMR-based identification and analysis of ecstasy tablets by GC-MS.Forensic Sci Int. 2023 Mar;344:111597. doi: 10.1016/j.forsciint.2023.111597. Epub 2023 Feb 3. Forensic Sci Int. 2023. PMID: 36801502
-
Khat and synthetic cathinones: a review.Arch Toxicol. 2014 Jan;88(1):15-45. doi: 10.1007/s00204-013-1163-9. Epub 2013 Dec 8. Arch Toxicol. 2014. PMID: 24317389 Review.
-
Synthetic cathinones: an evolving class of new psychoactive substances.Crit Rev Toxicol. 2019 Aug;49(7):549-566. doi: 10.1080/10408444.2019.1679087. Epub 2019 Nov 20. Crit Rev Toxicol. 2019. PMID: 31747318 Review.
-
"Legal Highs"--An Emerging Epidemic of Novel Psychoactive Substances.Int Rev Neurobiol. 2015;120:273-300. doi: 10.1016/bs.irn.2015.02.009. Epub 2015 Mar 23. Int Rev Neurobiol. 2015. PMID: 26070762 Review.
Cited by
-
The Designer Drug αPHP Affected Cell Proliferation and Triggered Deathly Mechanisms in Murine Neural Stem/Progenitor Cells.Biology (Basel). 2023 Sep 11;12(9):1225. doi: 10.3390/biology12091225. Biology (Basel). 2023. PMID: 37759624 Free PMC article.
-
Disposition Kinetics of Cathinone and its Metabolites after Oral Administration in Rats.Curr Drug Metab. 2024;25(3):220-226. doi: 10.2174/0113892002300638240513065512. Curr Drug Metab. 2024. PMID: 38752643
-
Music Therapy in Depression: Exploring Mechanisms and Efficacy in Rat Models.Brain Sci. 2025 Mar 25;15(4):338. doi: 10.3390/brainsci15040338. Brain Sci. 2025. PMID: 40309786 Free PMC article. Review.
-
3,4-Methylenedioxy methamphetamine, synthetic cathinones and psychedelics: From recreational to novel psychotherapeutic drugs.Front Psychiatry. 2022 Oct 3;13:990405. doi: 10.3389/fpsyt.2022.990405. eCollection 2022. Front Psychiatry. 2022. PMID: 36262632 Free PMC article. Review.
-
Synthetic cannabinoids use in a sample of opioid-use disorder patients.Front Psychiatry. 2022 Aug 3;13:956120. doi: 10.3389/fpsyt.2022.956120. eCollection 2022. Front Psychiatry. 2022. PMID: 35990071 Free PMC article.
References
-
- Specka M., Kuhlmann T., Sawazki J., Bonnet U., Steinert R., Cybulska-Rycicki M., Eich H., Zeiske B., Niedersteberg A., Schaaf L., et al. Prevalence of Novel Psychoactive Substance (NPS) Use in Patients Admitted to Drug Detoxification Treatment. Front. Psychiatry. 2020;11:569. doi: 10.3389/fpsyt.2020.00569. - DOI - PMC - PubMed
-
- United Nations Office on Drugs and Crime. [(accessed on 30 December 2021)]. Available online: https://www.unodc.org/documents/scientific/NPS_leaflet_2018_EN.PDF.
-
- United Nations Office on Drugs and Crime. [(accessed on 31 December 2021)]. Available online: https://www.unodc.org/LSS/Page/NPS.
-
- European Monitoring Centre for Drugs and Drug Addiction. [(accessed on 31 December 2021)]. Available online: https://op.europa.eu/en/publication-detail/-/publication/7bd409b6-44cd-1....
Publication types
LinkOut - more resources
Full Text Sources